Intrexon Corp. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
177,489.00
115,961.00
238,310.00
244,196.00
86,656.00
229,827
Total Accounts Receivable
7,357.00
29,264.00
52,294.00
42,485.00
39,841.00
28,078
Inventories
-
25,789.00
26,563.00
21,139.00
20,493.00
21,447
Other Current Assets
2,710.00
3,759.00
6,634.00
7,361.00
7,057.00
6,131
Total Current Assets
187,556.00
174,773.00
323,801.00
315,181.00
154,047.00
285,483
Net Property, Plant & Equipment
16,629.00
38,000.00
42,739.00
64,672.00
112,674.00
128,874
Total Investments and Advances
208,390.00
195,222.00
199,211.00
182,715.00
189,910.00
21,275
Long-Term Note Receivable
-
-
2,500.00
-
-
-
Intangible Assets
55,779.00
167,006.00
412,704.00
382,790.00
386,166.00
278,876
Other Assets
1,118.00
1,271.00
1,091.00
3,710.00
4,054.00
1,669
Total Assets
469,472.00
576,272.00
982,046.00
949,068.00
846,851.00
721,628
ST Debt & Current Portion LT Debt
30.00
3,948.00
1,491.00
1,206.00
735.00
Accounts Payable
1,057.00
6,267.00
4,967.00
8,918.00
9,014.00
Other Current Liabilities
18,742.00
37,267.00
69,446.00
84,481.00
70,424.00
Total Current Liabilities
19,829.00
47,482.00
75,904.00
94,605.00
80,173.00
Long-Term Debt
1,663.00
8,702.00
7,598.00
7,562.00
7,535.00
Deferred Taxes
-
-
21,802.00
17,007.00
15,620.00
Other Liabilities
66,637.00
110,799.00
171,856.00
260,646.00
196,978.00
Total Liabilities
88,129.00
166,983.00
277,160.00
379,820.00
300,306.00
Common Equity (Total)
366,722.00
384,761.00
694,078.00
560,237.00
533,631.00
Total Shareholders' Equity
366,722.00
384,761.00
694,078.00
560,237.00
533,631.00
Total Equity
381,343.00
409,289.00
704,886.00
569,248.00
546,545.00
Liabilities & Shareholders' Equity
469,472.00
576,272.00
982,046.00
949,068.00
846,851.00
Accumulated Minority Interest
14,621.00
24,528.00
10,808.00
9,011.00
12,914.00

About Intrexon

View Profile
Address
20374 Seneca Meadows Parkway
Germantown Maryland 20876
United States
Employees -
Website http://www.dna.com
Updated 07/08/2019
Intrexon Corp. is a biotechnology company, which engages in the business of synthetic biology. It focuses on on programming biological systems to alleviate disease, remediate environmental challenges, and provide sustainable food and industrial chemicals. The firm offers UltraVector, RheoSwitch, cell systems informatics, protein engineering, and antibody discovery.